Greg Delgoffe, PhD

Dr. Delgoffe is an associate professor in the Department of Immunology at the University of Pittsburgh and UPMC Hillman Cancer Center, and a co-Founder and Director of Novasenta. Dr. Delgoffe’s research program studies how immune cells sense and acquire metabolic fuel to support anti-cancer immune responses. He has published in several high impact journals (Nature, Immunity, Nature Immunology) and translated his findings into several novel clinical trials for cancer. 

Dr. Delgoffe brings an appreciation for several understudied mechanisms of immune suppression in cancer along with a passion and proven track record of reversing or redirecting immunoregulatory pathways to promote curative immunotherapeutic responses in patients. 

He earned his Ph.D in 2010 from Johns Hopkins School of Medicine and completed postdoctoral training at St. Jude Children’s Research Hospital in 2014.